TXA2 is a potent vasoconstrictor and a powerful inducer of platelet aggregation. Despite an intense interest in TXA2 and its involvement in numerous physiological functions, relatively little is known about the enzyme which controls its production (thromboxane synthase). Thromboxane synthase is a microsomal enzyme that is found in a number of tissues including platelets, lung and brain. The platelet enzyme is thought to play an important role in thrombosis and hemostasis; however, the function of this enzyme in lung and brain and the molecular similarities of the enzyme from different tissues is still unknown. Substantial purification of the enzyme from human platelets and bovine lung has been achieved in our laboratory using affinity chromatography. Affinity columns are made by coupling avidin to CNBr activated Sepharose 4B. The avidin is then used to remove thromboxane synthase that has been reacted with biotin-U63557A (A specific thromboxane synthase inhibitor). The further development of this method is being pursued. In addition we have produced and characterized a monoclonal antibody to thromboxane synthase. The antibody reacts to a single protein band when it is used in a Western blot of an SDS-PAGE electrogram of partially purified human platelet enzyme or bovine brain enzyme. The antibody reacts to two proteins in the partially purified bovine lung enzyme. Since our antibody appears to react with the enzyme from the platelet, lung and brain of several species, we hope to use it in the purification and immunological characterization of the enzyme from various tissues. The proposed research will provide basic biochemical information on the chemical, physical, immunological and kinetic characteristics of thromboxane synthase, thus aiding in the design of specific thromboxane synthase inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS023327-06
Application #
3882376
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
City
Houston
State
TX
Country
United States
Zip Code
77225
Chen, Pei-Feng; Wu, Kenneth K (2009) Two synthetic peptides corresponding to the proximal heme-binding domain and CD1 domain of human endothelial nitric-oxide synthase inhibit the oxygenase activity by interacting with CaM. Arch Biochem Biophys 486:132-40
Wu, Jui-Sheng; Cheung, Wai-Mui; Tsai, Yau-Sheng et al. (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119:1124-34
Liou, Jun-Yang; Ellent, David P; Lee, Sang et al. (2007) Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells 25:1096-103
Liou, Jun-Yang; Lee, Sang; Ghelani, Dipak et al. (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481-7
Cieslik, Katarzyna A; Deng, Wu-Guo; Wu, Kenneth K (2006) Essential role of C-Rel in nitric-oxide synthase-2 transcriptional activation: time-dependent control by salicylate. Mol Pharmacol 70:2004-14
Deng, Wu-Guo; Tang, Shao-Tzu; Tseng, Hui-Ping et al. (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108:518-24
Wu, Kenneth K (2006) Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol Biol 338:281-90
Lin, Teng-Nan; Cheung, Wai-Mui; Wu, Jui-Sheng et al. (2006) 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26:481-7
Wu, Kenneth K (2006) Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb Haemost 96:417-22
Liou, Jun-Yang; Aleksic, Nena; Chen, Shu-Fen et al. (2005) Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res 306:75-84

Showing the most recent 10 out of 63 publications